+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Excipients Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797826
The global pharmaceutical excipients market value was USD 8.3 billion in 2022, driven by the expanding pharmaceutical industry across the globe. The market size is anticipated to grow at a CAGR of 4.1% during the forecast period of 2023-2031 to achieve a value of USD 11.92 billion by 2031.

Pharmaceutical Excipients: Introduction

Pharmaceutical excipients are inert substances used in the formulation of drugs. They play a crucial role in drug delivery, stability, and overall effectiveness by facilitating drug absorption, enhancing solubility, and improving taste, texture, and appearance. Excipients are used in various dosage forms, including tablets, capsules, liquids, and injectables. Commonly used excipients include binders, fillers, disintegrants, lubricants, coatings, preservatives, and solvents.

The global pharmaceutical excipients market has been experiencing significant growth due to factors such as the expanding pharmaceutical industry, increasing demand for generic drugs, and advancements in drug delivery systems. Moreover, the rising prevalence of chronic diseases and the growing focus on biopharmaceuticals contribute to market growth.

Pharmaceutical Excipients Market Scenario

The global pharmaceutical excipients market is poised for significant growth as the demand for pharmaceutical products continues to rise. Factors such as the expanding pharmaceutical industry, increasing demand for generic drugs, and advancements in drug delivery systems contribute to the market's expansion. The market is characterized by regional dynamics shaped by pharmaceutical infrastructure, government support, and investment in research and development. However, challenges such as regulatory hurdles, the need for high-quality excipients, and supply chain complexities may impact market growth.

North America: The largest market for pharmaceutical excipients, driven by factors such as advanced pharmaceutical infrastructure, the presence of major pharmaceutical companies, and a robust research and development landscape.

Europe: The second-largest market, with increasing demand for excipients due to a growing elderly population, government support, and an expanding pharmaceutical sector.

Asia-Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of chronic diseases, and growing investments in pharmaceutical infrastructure and research.

Pharmaceutical Excipients Market Segmentations

Market Breakup by Product Type

Polymers

  • MCC
  • HPMC
  • Ethyl Cellulose
  • Methyl Cellulose
  • CMC
  • Croscarmellose Sodium
  • Povidone
  • Pregelatinized starch
  • Sodium starch glycolate
  • Polyethylene Glycol
  • Acrylic Polymers

Alcohols

  • Glycerin
  • Propylene Glycol
  • Sorbitol
  • Mannitol
  • Others

Sugars

  • Lactose
  • Sucrose
  • Others

Minerals

  • Calcium Phosphate
  • Calcium Carbonate
  • Calcium Sulfate
  • Clay
  • Silicon Dioxide
  • Titanium Dioxide
  • Others
  • Gelatins
  • Others

Market Breakup by Functionality

Binders and Adhesives

  • Organic
  • Inorganic

Disintegrants

  • Organic
  • Inorganic

Coating Material

  • Organic
  • Inorganic

Colouring Agents

  • Organic
  • Inorganic

Solubilizers

  • Organic
  • Inorganic

Flavours

  • Organic
  • Inorganic

Sweetening Agents

  • Organic
  • Inorganic

Diluents

  • Organic
  • Inorganic

Lubricants

  • Organic
  • Inorganic

Buffers

  • Organic
  • Inorganic

Emulsifying Agents

  • Organic
  • Inorganic

Preservatives

  • Organic
  • Inorganic

Antioxidants

  • Organic
  • Inorganic

Sorbents

  • Organic
  • Inorganic

Solvents

  • Organic
  • Inorganic

Emollients

  • Organic
  • Inorganic

Glidants

  • Organic
  • Inorganic

Chelating Agents

  • Organic
  • Inorganic

Antifoaming Agents

  • Organic
  • Inorganic
  • Others

Market Breakup by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Formulators
  • Research Organization and Academics
  • Others

Market by Distribution Channel

  • Direct Tender
  • Retail Sales
  • E-Commerce
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Global Pharmaceutical Excipients Market

Some key trends of the market are as follows:
  • Growing demand for generic drugs: With the increasing need for affordable medication, the demand for generic drugs is rising, driving the demand for pharmaceutical excipients
  • Technological advancements: Innovations in drug delivery systems, such as nanotechnology and targeted drug delivery, are fostering the development of novel excipients
  • Expansion of the pharmaceutical industry: The growing pharmaceutical industry, particularly in emerging markets, is propelling the demand for excipients

Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Kerry Group plc
  • DFE Pharma
  • Cargill
  • Incorporated
  • Pfanstiehl
  • Colorcon
  • MEGGLE GmbH & Co. KG
  • Roquette Frères
  • The Lubrizol Corporation
  • BASF SE
  • Avantor Inc
  • BENEO
  • Chemie Trade

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pharmaceutical Excipients Market Overview
3.1 Global Pharmaceutical Excipients Market Historical Value (2016-2022)
3.2 Global Pharmaceutical Excipients Market Forecast Value (2023-2031)
4 Global Pharmaceutical Excipients Market Landscape
4.1 Global Pharmaceutical Excipients Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pharmaceutical Excipients Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Functionality
4.2.3 Analysis by End Users
5 Global Pharmaceutical Excipients Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pharmaceutical Excipients Market Segmentation
6.1 Global Pharmaceutical Excipients Market by Product Type
6.1.1 Market Overview
6.1.2 Polymers
6.1.2.1 MCC
6.1.2.2 HPMC
6.1.2.3 Ethyl Cellulose
6.1.2.4 Methyl Cellulose
6.1.2.5 CMC
6.1.2.6 Croscarmellose Sodium
6.1.2.7 Povidone
6.1.2.8 Pregelatinized starch
6.1.2.9 Sodium starch glycolate
6.1.2.10 Polyethylene Glycol
6.1.2.11 Acrylic Polymers
6.1.3 Alcohols
6.1.3.1 Glycerin
6.1.3.2 Propylene Glycol
6.1.3.3 Sorbitol
6.1.3.4 Mannitol
6.1.3.5 Others
6.1.4 Sugars
6.1.4.1 Lactose
6.1.4.2 Sucrose
6.1.4.3 Others
6.1.5 Minerals
6.1.5.1 Calcium Phosphate
6.1.5.2 Calcium Carbonate
6.1.5.3 Calcium Sulfate
6.1.5.4 Clay
6.1.5.5 Silicon Dioxide
6.1.5.6 Titanium Dioxide
6.1.5.7 Others
6.1.6 Gelatins
6.1.7 Others
6.2 Global Pharmaceutical Excipients Market by Functionality
6.2.1 Market Overview
6.2.2 Binders and Adhesives
6.2.2.1 Organic
6.2.2.2 Inorganic
6.2.3 Disintegrants
6.2.3.1 Organic
6.2.3.2 Inorganic
6.2.4 Coating Material
6.2.4.1 Organic
6.2.4.2 Inorganic
6.2.5 Coloring Agents
6.2.5.1 Organic
6.2.5.2 Inorganic
6.2.6 Solubilizers
6.2.6.1 Organic
6.2.6.2 Inorganic
6.2.7 Flavors
6.2.7.1 Organic
6.2.7.2 Inorganic
6.2.8 Sweetening Agents
6.2.8.1 Organic
6.2.8.2 Inorganic
6.2.9 Diluents
6.2.9.1 Organic
6.2.9.2 Inorganic
6.2.10 Lubricants
6.2.10.1 Organic
6.2.10.2 Inorganic
6.2.11 Buffers
6.2.11.1 Organic
6.2.11.2 Inorganic
6.2.12 Emulsifying Agents
6.2.12.1 Organic
6.2.12.2 Inorganic
6.2.13 Preservatives
6.2.13.1 Organic
6.2.13.2 Inorganic
6.2.14 Antioxidants
6.2.14.1 Organic
6.2.14.2 Inorganic
6.2.15 Sorbents
6.2.15.1 Organic
6.2.15.2 Inorganic
6.2.16 Solvents
6.2.16.1 Organic
6.2.16.2 Inorganic
6.2.17 Emollients
6.2.17.1 Organic
6.2.17.2 Inorganic
6.2.18 Glidants
6.2.18.1 Organic
6.2.18.2 Inorganic
6.2.19 Chelating Agents
6.2.19.1 Organic
6.2.19.2 Inorganic
6.2.20 Antifoaming Agents
6.2.20.1 Organic
6.2.20.2 Inorganic
6.2.21 Others
6.3 Global Pharmaceutical Excipients Market by End User
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biopharmaceutical Companies
6.3.3 Contract Formulators
6.3.4 Research Organization and Academics
6.3.5 Others
6.4 Global Pharmaceutical Excipients Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Direct Tender
6.4.3 Retail Sales
6.4.4 E-Commerce
6.4.5 Others
6.5 Global Pharmaceutical Excipients Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Pharmaceutical Excipients Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pharmaceutical Excipients Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pharmaceutical Excipients Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pharmaceutical Excipients Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pharmaceutical Excipients Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Kerry Group plc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 DFE Pharma
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Cargill
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Incorporated
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Pfanstiehl
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Colorcon
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 MEGGLE GmbH & Co. KG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Roquette Frères
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 The Lubrizol Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BASF SE
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Avantor Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BENEO
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Chemie Trade
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Pharmaceutical Excipients Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Kerry Group plc.
  • Dfe Pharma
  • Cargill
  • Incorporated
  • Pfanstiehl
  • Colorcon
  • Meggle GmbH & Co. Kg
  • Roquette Frères
  • The Lubrizol Corporation
  • Basf Se
  • Avantor Inc.
  • Beneo
  • Chemie Trade

Methodology

Loading
LOADING...

Table Information